Logo image
IRO Home Research units Researcher Profiles
Sign in
Commentary RE: Tolterodine Once Daily: Superior Efficacy and Tolerability in the Treatment of the Overactive Bladder
Journal article

Commentary RE: Tolterodine Once Daily: Superior Efficacy and Tolerability in the Treatment of the Overactive Bladder

Karl J. Kreder
Urology (Ridgewood, N.J.), Vol.145, pp.323-323
11/01/2020
DOI: 10.1016/j.urology.2020.04.039
PMID: 32305549

View Online

Abstract

no abstract | commentary
Life Sciences & Biomedicine Science & Technology Urology & Nephrology

Details

Metrics

2 Record Views
Logo image